RBP4 (mouse/rat) Dual ELISA Kit

Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes: Y.M. Cho, et al.; Diabetes Care 29, 2457 (2006)

High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans: N. Stefan, et al.; Diabetes Care 30, 1173 (2007)

Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice: R. Sasaki, et al.; Biochem. Pharmacol. 74, 1619 (2007)

Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice: N. Mody, et al.; Am. J. Physiol. Endocrinol. Metab. 294, E785 (2008)

Identification and characterization of a non-retinoid ligand for retinolbinding protein 4 which lowers serum retinol-binding protein 4 levels in vivo: A. Motani, et al.; J. Biol. Chem. 284, 7673 (2009)

Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease: K.S. Collison, et al.; J. Lipid Res. 50, 1521 (2009)

Diabetes of the Liver: The Link Between nonalcoholic fatty liver disease and HFCS-55: K.S. Collison, et al.; Obesity 17, 2003 (2009)

Early postnatal oestradiol exposure causes insulin resistance and signs of inflammation in circulation and skeletal muscle: C. Alexanderson, et al.; J. Endocrinol. 201, 49 (2009)

Dietary trans-fat combined with monosodium glutamate induces dyslipidemia and impairs spatial memory: K.S. Collison, et al.; Physiol. Behav. 99, 334 (2010)

Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat: K.S. Collison, et al.; Obesity (Silver Spring) 18, 1122 (2010)